Kairos Pharma Ltd. (KAPA)
1.73
-0.08
(-4.42%)
USD |
NYAM |
Sep 18, 16:00
1.75
+0.02
(+1.16%)
After-Hours: 20:00
Kairos Pharma Total Liabilities (Quarterly) : 0.265M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.265M |
| March 31, 2026 | 0.431M |
| December 31, 2025 | 0.438M |
| September 30, 2025 | 0.402M |
| June 30, 2025 | 0.676M |
| March 31, 2025 | 0.805M |
| December 31, 2024 | 1.44M |
| September 30, 2024 | 1.672M |
| Date | Value |
|---|---|
| June 30, 2024 | 3.684M |
| March 31, 2024 | 3.373M |
| December 31, 2023 | 3.043M |
| September 30, 2023 | 2.821M |
| June 30, 2023 | 2.539M |
| March 31, 2023 | 2.33M |
| December 31, 2022 | 2.215M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.456M |
| Shareholders Equity (Quarterly) | 4.191M |
| Current Ratio | 11.98 |